Condition 1: Preeclampsia. Condition 2: Fetal growth restriction. Mild to moderate pre-eclampsia Newborn small for gestational age
Conditions
Interventions
Intervention 1: Intervention group: Take one dose of aspirin 80 mg daily until 34 weeks of gestation. Intervention 2: Control group: Take one dose of placebo daily until 34 weeks of gestation.
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age 18-40 Single pregnancy Tends to participate in the study Non underlying known disease such as chronic hypertension, liver disease, kidney disease, diabetes mellitus No using aspirin or allergy history BMI=30 No ultrasound findings On NT, mean PI Ut>1.5 or PAPPA <0.4 No history of previous preeclampsia No history of previous fetal growth restriction Normality of tests and screening
Exclusion criteria
Exclusion criteria: Unwillingness to participate in study Not available for evaluations Abortion and preterm delivery for reasons other than preeclampsia and fetal growth restriction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preeclamsia. Timepoint: End of pregnancy. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fetal growth retardation. Timepoint: End of pregnancy. Method of measurement: Sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Sadeghian
Yasouj University of Medical Sciences
Outcome results
None listed